Literature DB >> 30117097

Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial-Host Interactions Facilitate the Bacterial Pathogen Invading the Brain.

Mazen M Jamil Al-Obaidi1, Mohd Nasir Mohd Desa2,3.   

Abstract

This review aims to elucidate the different mechanisms of blood brain barrier (BBB) disruption that may occur due to invasion by different types of bacteria, as well as to show the bacteria-host interactions that assist the bacterial pathogen in invading the brain. For example, platelet-activating factor receptor (PAFR) is responsible for brain invasion during the adhesion of pneumococci to brain endothelial cells, which might lead to brain invasion. Additionally, the major adhesin of the pneumococcal pilus-1, RrgA is able to bind the BBB endothelial receptors: polymeric immunoglobulin receptor (pIgR) and platelet endothelial cell adhesion molecule (PECAM-1), thus leading to invasion of the brain. Moreover, Streptococcus pneumoniae choline binding protein A (CbpA) targets the common carboxy-terminal domain of the laminin receptor (LR) establishing initial contact with brain endothelium that might result in BBB invasion. Furthermore, BBB disruption may occur by S. pneumoniae penetration through increasing in pro-inflammatory markers and endothelial permeability. In contrast, adhesion, invasion, and translocation through or between endothelial cells can be done by S. pneumoniae without any disruption to the vascular endothelium, upon BBB penetration. Internalins (InlA and InlB) of Listeria monocytogenes interact with its cellular receptors E-cadherin and mesenchymal-epithelial transition (MET) to facilitate invading the brain. L. monocytogenes species activate NF-κB in endothelial cells, encouraging the expression of P- and E-selectin, intercellular adhesion molecule 1 (ICAM-1), and Vascular cell adhesion protein 1 (VCAM-1), as well as IL-6 and IL-8 and monocyte chemoattractant protein-1 (MCP-1), all these markers assist in BBB disruption. Bacillus anthracis species interrupt both adherens junctions (AJs) and tight junctions (TJs), leading to BBB disruption. Brain microvascular endothelial cells (BMECs) permeability and BBB disruption are induced via interendothelial junction proteins reduction as well as up-regulation of IL-1α, IL-1β, IL-6, TNF-α, MCP-1, macrophage inflammatory proteins-1 alpha (MIP1α) markers in Staphylococcus aureus species. Streptococcus agalactiae or Group B Streptococcus toxins (GBS) enhance IL-8 and ICAM-1 as well as nitric oxide (NO) production from endothelial cells via the expression of inducible nitric oxide synthase (iNOS) enhancement, resulting in BBB disruption. While Gram-negative bacteria, Haemophilus influenza OmpP2 is able to target the common carboxy-terminal domain of LR to start initial interaction with brain endothelium, then invade the brain. H. influenza type b (HiB), can induce BBB permeability through TJ disruption. LR and PAFR binding sites have been recognized as common routes of CNS entrance by Neisseria meningitidis. N. meningitidis species also initiate binding to BMECs and induces AJs deformation, as well as inducing specific cleavage of the TJ component occludin through the release of host MMP-8. Escherichia coli bind to BMECs through LR, resulting in IL-6 and IL-8 release and iNOS production, as well as resulting in disassembly of TJs between endothelial cells, facilitating BBB disruption. Therefore, obtaining knowledge of BBB disruption by different types of bacterial species will provide a picture of how the bacteria enter the central nervous system (CNS) which might support the discovery of therapeutic strategies for each bacteria to control and manage infection.

Entities:  

Keywords:  Bacterial infection; Blood brain barrier; Meningitis; Therapeutic strategies

Mesh:

Year:  2018        PMID: 30117097     DOI: 10.1007/s10571-018-0609-2

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  180 in total

1.  A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1.

Authors:  Nemani V Prasadarao; Anna M Blom; Bruno O Villoutreix; Linette C Linsangan
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

Review 2.  Conquering the meningococcus.

Authors:  David S Stephens
Journal:  FEMS Microbiol Rev       Date:  2007-01       Impact factor: 16.408

3.  Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models.

Authors:  Carlos J Orihuela; Jafar Mahdavi; Justin Thornton; Beth Mann; Karl G Wooldridge; Noha Abouseada; Neil J Oldfield; Tim Self; Dlawer A A Ala'Aldeen; Elaine I Tuomanen
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

Review 4.  Listeriolysin O: a key protein of Listeria monocytogenes with multiple functions.

Authors:  Samer Kayal; Alain Charbit
Journal:  FEMS Microbiol Rev       Date:  2006-07       Impact factor: 16.408

5.  Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: an electron microscopic study.

Authors:  L Greiffenberg; W Goebel; K S Kim; J Daniels; M Kuhn
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  Listeriolysin O secreted by Listeria monocytogenes induces NF-kappaB signalling by activating the IkappaB kinase complex.

Authors:  Samer Kayal; Alain Lilienbaum; Olivier Join-Lambert; Xiaoxia Li; Alain Israël; Patrick Berche
Journal:  Mol Microbiol       Date:  2002-06       Impact factor: 3.501

7.  PCR detection of Staphylococcal enterotoxins (SEs) N, O, P, Q, R, U, and survey of SE types in Staphylococcus aureus isolates from food-poisoning cases in Taiwan.

Authors:  Yu-Cheng Chiang; Wan-Wen Liao; Chin-Ming Fan; Wan-Yu Pai; Chien-Shun Chiou; Hau-Yang Tsen
Journal:  Int J Food Microbiol       Date:  2007-11-01       Impact factor: 5.277

8.  Routine quantitative blood cultures in children with Haemophilus influenzae or Streptococcus pneumoniae bacteremia.

Authors:  L M Bell; G Alpert; J M Campos; S A Plotkin
Journal:  Pediatrics       Date:  1985-12       Impact factor: 7.124

9.  Spatial localization of bacteria controls coagulation of human blood by 'quorum acting'.

Authors:  Christian J Kastrup; James Q Boedicker; Andrei P Pomerantsev; Mahtab Moayeri; Yao Bian; Rebecca R Pompano; Timothy R Kline; Patricia Sylvestre; Feng Shen; Stephen H Leppla; Wei-Jen Tang; Rustem F Ismagilov
Journal:  Nat Chem Biol       Date:  2008-12       Impact factor: 15.040

Review 10.  Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.

Authors:  James P Watt; Lara J Wolfson; Katherine L O'Brien; Emily Henkle; Maria Deloria-Knoll; Natalie McCall; Ellen Lee; Orin S Levine; Rana Hajjeh; Kim Mulholland; Thomas Cherian
Journal:  Lancet       Date:  2009-09-12       Impact factor: 79.321

View more
  37 in total

Review 1.  Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders.

Authors:  Hema Kumari Alajangi; Mandeep Kaur; Akanksha Sharma; Sumedh Rana; Shipali Thakur; Mary Chatterjee; Neha Singla; Pradeep Kumar Jaiswal; Gurpal Singh; Ravi Pratap Barnwal
Journal:  Mol Brain       Date:  2022-06-01       Impact factor: 4.399

2.  High-Dose Acetaminophen Alters the Integrity of the Blood-Brain Barrier and Leads to Increased CNS Uptake of Codeine in Rats.

Authors:  Junzhi Yang; Robert D Betterton; Erica I Williams; Joshua A Stanton; Elizabeth S Reddell; Chidinma E Ogbonnaya; Emma Dorn; Thomas P Davis; Jeffrey J Lochhead; Patrick T Ronaldson
Journal:  Pharmaceutics       Date:  2022-04-27       Impact factor: 6.525

3.  Host HSPD1 Translocation from Mitochondria to the Cytoplasm Induced by Streptococcus suis Serovar 2 Enolase Mediates Apoptosis and Loss of Blood-Brain Barrier Integrity.

Authors:  Tong Wu; Li Jia; Siyu Lei; Hexiang Jiang; Jianan Liu; Na Li; Paul R Langford; Hongtao Liu; Liancheng Lei
Journal:  Cells       Date:  2022-06-29       Impact factor: 7.666

Review 4.  Alcohol, inflammation, and blood-brain barrier function in health and disease across development.

Authors:  A S Vore; T Deak
Journal:  Int Rev Neurobiol       Date:  2021-08-11       Impact factor: 4.280

5.  Endothelial Dysfunction and Impaired Neurovascular Coupling Responses Precede Cognitive Impairment in a Mouse Model of Geriatric Sepsis.

Authors:  Tamas Csipo; Benjamin R Cassidy; Priya Balasubramanian; Douglas A Drevets; Zoltan I Ungvari; Andriy Yabluchanskiy
Journal:  Front Aging Neurosci       Date:  2021-05-14       Impact factor: 5.750

6.  Interleukin-17A Contributed to the Damage of Blood-CNS Barriers During Streptococcus suis Meningitis.

Authors:  Lei Xu; Xi Lu; Peng Xiao; Ran Liu; Kunlong Xia; Meizhou Wu; Meilin Jin; Anding Zhang
Journal:  Mol Neurobiol       Date:  2022-01-19       Impact factor: 5.682

7.  Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.

Authors:  Tamàs Fülöp; Usma Munawara; Anis Larbi; Mathieu Desroches; Serafim Rodrigues; Michele Catanzaro; Andrea Guidolin; Abdelouahed Khalil; François Bernier; Annelise E Barron; Katsuiku Hirokawa; Pascale B Beauregard; David Dumoulin; Jean-Philippe Bellenger; Jacek M Witkowski; Eric Frost
Journal:  CNS Drugs       Date:  2020-07       Impact factor: 6.497

8.  Infection-Induced Systemic Inflammation Is a Potential Driver of Alzheimer's Disease Progression.

Authors:  Vijayasree V Giridharan; Faisal Masud; Fabricia Petronilho; Felipe Dal-Pizzol; Tatiana Barichello
Journal:  Front Aging Neurosci       Date:  2019-05-28       Impact factor: 5.750

Review 9.  NLRC5: A Potential Target for Central Nervous System Disorders.

Authors:  Lu Zhang; Cui Jiao; Lingjuan Liu; Aiping Wang; Li Tang; Yi Ren; Peng Huang; Jie Xu; Dingan Mao; Liqun Liu
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

10.  Neuronal Damage and Neuroinflammation, a Bridge Between Bacterial Meningitis and Neurodegenerative Diseases.

Authors:  Kristine Farmen; Miguel Tofiño-Vian; Federico Iovino
Journal:  Front Cell Neurosci       Date:  2021-06-03       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.